Inspire Medical sees FY25 EPS $2.10-$2.20, consensus $1.94

Backs FY25 revenue view $940M-$955M, consensus $948.66M. The company said, “Inspire’s previously announced full year 2025 revenue guidance remains between $940 million to $955 million, which represents expected growth of 17% to 19% over full year 2024 revenue of $802.8 million. Gross margin for the full year is anticipated to be in the range of 84% to 86%. Inspire is introducing full year 2025 diluted earnings per share guidance of $2.10 to $2.20.”